Benjamin F. Edwards & Company, Inc. Rubius Therapeutics, Inc. Transaction History

Benjamin F. Edwards & Company, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 05, 2019	SELL	$7.85 - $15.75 $4,121 - $8,268	-525 Closed	0 $0
Q2 2019 Aug 08, 2019	SELL	$13.5 - $19.94 $10,800 - $15,952	-800 Reduced 60.38%	525 $8,000
Q1 2019 May 15, 2019	BUY	$13.27 - $18.51 $13,270 - $18,510	1,000 Added 307.69%	1,325 $24,000
Q4 2018 Jan 31, 2019	BUY	$13.83 - $22.97 $4,494 - $7,465	325 New	325 $5,000

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.